SCHEMBL7174657

SCHEMBL7174657

CCOC(=O)c1c([AsH2])c2cc(C(=O)OC)ccc2n1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 5/20 0.39
KDM4E B2RXH2 1/20 0.39
CACNA1B Q00975 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
HTT P42858 1/20 0.37
ATM Q13315 1/20 0.36
HCRTR1 O43613 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30961750 0.87 MAPT (0.44) MDM2KDM4ECACNA1BNPC1RAB9A
SCHEMBL19255038 0.76 CA12 (0.41) KDM4ECACNA1BRAB9AMEN1ALDH1A1
SCHEMBL3195065 0.76 HCRTR1 (0.43) KDM4ECACNA1BRAB9AMEN1ALDH1A1
SCHEMBL3194957 0.76 HSD17B2 (0.41) KDM4ECACNA1BNPC1RAB9AMEN1
SCHEMBL16064638 0.76 CNR2 (0.47) KDM4EALDH1A1GABRG2GABRB3GABRA5
SCHEMBL19013032 0.73 L3MBTL1 (0.51) MDM2KDM4ERAB9AALDH1A1MAPT
SCHEMBL30961753 0.72 GABRG2 (0.52) MDM2KDM4ECACNA1BNPC1RAB9A
SCHEMBL12228528 0.72 MDM2 (0.47) MDM2KDM4ECACNA1BALDH1A1HPGD
SCHEMBL3196664 0.71 ALDH1A1 (0.37) MDM2KDM4ECACNA1BRAB9AMEN1
SCHEMBL4783390 0.70 KDM4E (0.43) KDM4ENPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004111052-A1 PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR) XENOVA LIMITED (GB) 2004-12-23 WO disclosed